Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Stage D0 Relapsed Androgen Sensitive Prostate Cancer
NCT00454571Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in prostate cancer (PCa), sponsored by National Cancer Institute. Started Jun 2006; status: completed.
02
Drugs
pazopanib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00454571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454571.